ARNA - Arena Pharmaceuticals Inc
Previous close
99.99
0 0%
Share volume: 0
Last Updated: Thu 10 Mar 2022 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$99.99
0.00
0.00%
Summary score
16%
Profitability
0%
Dept financing
4%
Liquidity
75%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 31-Dec-2017 - 31-Dec-2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-5.4%
Return on assets
-4.94%
Return on sales
-380002.92%
Return on invested capital
-8.42%
Total debt ratio
9.96%
Debt ratio change over timeo
-1.08%
Current Ratio
21.8%
Quick Ratio
17.51%
Cash Position Ratio
14.02%
Short-term ratios 31-Dec-2020 - 31-Dec-2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
-18.39%
Return on assets
-14.39%
Return on sales
-280320.37%
Return on invested capital
-436.59%
Total debt ratio
11.02%
Debt ratio change over timeo
-1.05%
Current Ratio
15.57%
Quick Ratio
15.57%
Cash Position Ratio
15.17%
Last quarter ratios 31-Dec-2021
The data are presented for the financials results of the last quarter.
Return on equity
-23.11%
Return on assets
-19.29%
Return on sales
-280320.37%
Return on invested capital
-104.49%
Total debt ratio
14.21%
Debt ratio change over time
-1.14%
Current Ratio
8.59%
Quick Ratio
8.59%
Cash Position Ratio
8.3%
Performance ratios (change over 4 years) 31-Dec-2017 - 31-Dec-2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-81.26%
Return on assets
-80.41%
Return on sales
264837.69%
Return on invested capital
97%
Total debt ratio
-108.28%
Debt ratio change over time
-1.08%
Current Ratio
-16.16%
Quick Ratio
-8.18%
Cash Position Ratio
-4.95%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | ARNA | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | -5.4% | 0% | 0% | 16.71% |
Return on assets | -4.94% | 0% | 0% | -9.63% |
Return on sales | -380002.92% | 0% | 0% | -2409.01% |
Return on invested capital | -8.42% | 0% | 0% | 60.56% |
Profitability | 0% | 0% | 50% | 50% |
Total debt ratio | 9.96% | 0% | 0% | 93.26% |
Debt ratio change over time | -1.08% | 0% | 0% | 0.46% |
Dept financing | 3% | 0% | 0% | 50% |
Current Ratio | 15.57% | 0% | 0% | 7.6% |
Quick Ratio | 15.57% | 0% | 0% | 7.6% |
Cash Position Ratio | 15.17% | 0% | 0% | 7.46% |
Liquididy | 75% | 0% | 0% | 27% |
Short-term ratios | ARNA | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | -18.39% | 0% | 0% | -28.85% |
Return on assets | -14.39% | 0% | 0% | -8.04% |
Return on sales | -280320.37% | 0% | 0% | -4243.29% |
Return on invested capital | -436.59% | 0% | 0% | 23.36% |
Profitability | 0% | 0% | 75% | 25% |
Total debt ratio | 11.02% | 0% | 0% | 63.51% |
Debt ratio change over time | -1.05% | 0% | 0% | -0.49% |
Dept financing | 4% | 0% | 25% | 25% |
Current Ratio | 15.57% | 0% | 0% | 7.6% |
Quick Ratio | 15.57% | 0% | 0% | 7.6% |
Cash Position Ratio | 15.17% | 0% | 0% | 7.46% |
Liquididy | 75% | 0% | 0% | 37% |